These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1850405)

  • 1. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.
    Vilcek J; Lee TH
    J Biol Chem; 1991 Apr; 266(12):7313-6. PubMed ID: 1850405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytokines and receptors--their functions, structures and cloning of code genes. Tumor necrosis factor].
    Niitsu Y; Watanabe N
    Nihon Rinsho; 1988 May; 46(5):1041-9. PubMed ID: 2842520
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour necrosis factor. Improving on the formula.
    Balkwill F
    Nature; 1993 Jan; 361(6409):206-7. PubMed ID: 8380903
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin.
    Jäättelä M
    Lab Invest; 1991 Jun; 64(6):724-42. PubMed ID: 1646350
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha.
    Newton RC; Decicco CP
    J Med Chem; 1999 Jul; 42(13):2295-314. PubMed ID: 10395470
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of tumor necrosis factor receptors on phagocytes.
    Ding AH; Porteu F
    Proc Soc Exp Biol Med; 1992 Sep; 200(4):458-65. PubMed ID: 1354872
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour necrosis factor signal transduction.
    Krönke M; Schütze S; Scheurich P; Meichle A; Hensel G; Thoma B; Kruppa G; Pfizenmaier K
    Cell Signal; 1990; 2(1):1-8. PubMed ID: 2176798
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between novel tumor necrosis factor-alpha mutants and receptors on tumor and normal cells.
    Nakamura S; Masegi T; Fukuoka M; Kitai K; Kato A; Ichikawa Y; Watanabe N; Niitsu Y
    Agric Biol Chem; 1991 Jan; 55(1):53-7. PubMed ID: 1369315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor.
    Tartaglia LA; Goeddel DV
    J Biol Chem; 1992 Mar; 267(7):4304-7. PubMed ID: 1311304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA.
    Kalthoff H; Roeder C; Brockhaus M; Thiele HG; Schmiegel W
    J Biol Chem; 1993 Feb; 268(4):2762-6. PubMed ID: 8381414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The divergent receptors for TNF.
    Sprang SR
    Trends Biochem Sci; 1990 Oct; 15(10):366-8. PubMed ID: 2174582
    [No Abstract]   [Full Text] [Related]  

  • 12. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades.
    Wiegmann K; Schütze S; Kampen E; Himmler A; Machleidt T; Krönke M
    J Biol Chem; 1992 Sep; 267(25):17997-8001. PubMed ID: 1325455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.
    Zhang XM; Weber I; Chen MJ
    J Biol Chem; 1992 Nov; 267(33):24069-75. PubMed ID: 1331108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts.
    Vilcek J; Tsujimoto M; Palombella VJ; Kohase M; Le J
    J Cell Physiol Suppl; 1987; Suppl 5():57-61. PubMed ID: 2824534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes.
    Gill RM; Ni J; Hunt JS
    Am J Pathol; 2002 Dec; 161(6):2011-7. PubMed ID: 12466117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.
    Migone TS; Zhang J; Luo X; Zhuang L; Chen C; Hu B; Hong JS; Perry JW; Chen SF; Zhou JX; Cho YH; Ullrich S; Kanakaraj P; Carrell J; Boyd E; Olsen HS; Hu G; Pukac L; Liu D; Ni J; Kim S; Gentz R; Feng P; Moore PA; Ruben SM; Wei P
    Immunity; 2002 Mar; 16(3):479-92. PubMed ID: 11911831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
    Lewis M; Tartaglia LA; Lee A; Bennett GL; Rice GC; Wong GH; Chen EY; Goeddel DV
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2830-4. PubMed ID: 1849278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation.
    Beutler B
    Am J Med Sci; 1992 Feb; 303(2):129-33. PubMed ID: 1311496
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms controlling the level of receptors for tumor necrosis factor.
    Holtmann H; Brakebusch C; König M; Klocke R; Winzen R; Resch K; Wallach D
    Agents Actions; 1991 Jan; 32(1-2):106-8. PubMed ID: 1647647
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor necrosis factor: biology and therapeutic inhibitors.
    Papadakis KA; Targan SR
    Gastroenterology; 2000 Oct; 119(4):1148-57. PubMed ID: 11040201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.